Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Halozyme Therapeutics, Inc. (HALO)

« Back to company index

HALO Chatter Timeline

Stock Ticker for HALO

Most Active Tweeters for HALO

UserTweets
@bilalv87 3
@Tickeron 3
@iamToddyTickles 2
@Wattwurm73 2
@TickerReport 2

Recent Tweets for HALO

bilalv87 @bilalv87
RT @iamToddyTickles: Kiran Sidhu is as smart, genuine and relatable as CEO’s come. $HALO @halolabsinc https://t.co/6n7d1lr1x1
11:09am
bilalv87 @bilalv87
RT @iamToddyTickles: $HALO working with Caliva who has partnered with the one and only Mr. Shawn Carter (yes) JAY-Z!! ? ? https://t.co/3Sv7…
11:09am
iamToddyTickles @iamToddyTickles
$HALO working with Caliva who has partnered with the one and only Mr. Shawn Carter (yes) JAY-Z!! ? ? https://t.co/3Sv71zO76Q
9:09am
SandFlorentin @SandFlorentin
RT @halolabsinc: CEO of $HALO Kiran Sidhu sits down with @iamToddyTickles on SiriusXM Canada to discuss legalization and supply agreement w…
7:09am
Biotech2050 @Biotech2050
RT @Wattwurm73: $HALO Roche Pharma Day slide 46 showing Herceptin + Perjeta FDC SC (Enhanze) significant time savings administration IV vs…
6:09am
Wattwurm73 @Wattwurm73
$HALO Roche Pharma Day slide 46 showing Herceptin + Perjeta FDC SC (Enhanze) significant time savings administratio… https://t.co/GGsEC7c2mA
4:09am
Tickeron @Tickeron
$HALO's Aroon indicator reaches into Uptrend on September 13, 2019. View odds for this and other indicators:… https://t.co/SBAVFyV7ag
4:09am
halolabsinc @halolabsinc
CEO of $HALO Kiran Sidhu sits down with @iamToddyTickles on SiriusXM Canada to discuss legalization and supply agre… https://t.co/loFLFRk0ZL
September 15th 2019, 6:09pm
iamToddyTickles @iamToddyTickles
Kiran Sidhu is as smart, genuine and relatable as CEO’s come. $HALO @halolabsinc https://t.co/6n7d1lr1x1
September 15th 2019, 3:09pm
biotechw2019 @biotechw2019
$HALO is making a higher low ascending triangle since the gap total filled ! https://t.co/RMxfVsYamj
September 15th 2019, 1:09pm
FirstRareBooks @FirstRareBooks
@endpts @dhovekamp42 $HALO makes that recently approved IV Tecentriq Combination for NSCLC Subcutaneous https://t.co/VGMgJhu7C7
September 15th 2019, 12:09pm
ShaaRedNL @ShaaRedNL
$HALO Liking their ECM degradation technology. Stock should be valued much higher. Looking to add next week. https://t.co/bwAXO08I88
September 14th 2019, 4:09pm
ZolmaxNews @ZolmaxNews
Halozyme Therapeutics $HALO Downgraded to “Hold” at ValuEngine https://t.co/uvMUIh2A3r
September 14th 2019, 5:09am
CompoundStock13 @CompoundStock13
RT @lastprince416: Halo Labs Signs Bulk Extract Supply Agreement With Caliva $HALO #NEOexchange #USMSO #potstocks #weedstocks https://t.co…
September 13th 2019, 9:09pm
mmjinvesting @mmjinvesting
Reason for the full session halt on @halolabsinc $HALO Halo Labs Inc. has entered into a bulk supply agreement wit… https://t.co/Zy2MtN7SfR
September 13th 2019, 6:09pm
Tickeron @Tickeron
$HALO's Aroon indicator reaches into Uptrend on September 12, 2019. View odds for this and other indicators:… https://t.co/hlxEAK2jOj
September 13th 2019, 5:09pm
jimrockfordatSH @jimrockfordatSH
RT @TheDeepDive_ca: $HALO halted pending news
September 13th 2019, 5:09pm
junglejava1 @junglejava1
Halo Signs Bulk Extract Supply Agreement With Caliva $HALO https://t.co/09bpY9C7ch
September 13th 2019, 5:09pm
lastprince416 @lastprince416
Halo Labs Signs Bulk Extract Supply Agreement With Caliva $HALO #NEOexchange #USMSO #potstocks #weedstocks https://t.co/OLAtmg3YbK
September 13th 2019, 5:09pm
MaisaCorp @MaisaCorp
$HALO phase 3 FeDeriCa study evaluating a fixed-dose subcutaneous combination of two breast cancer drugs using the… https://t.co/p9o3WO9D2s
September 13th 2019, 4:09pm
bilalv87 @bilalv87
RT @ToddShapiroShow: "Legalization - Everyone Looking To Be Part Of Movement" #HaloLabs' Kiran Sidhu w/ @iamToddyTickles $HALO https://t.co…
September 13th 2019, 2:09pm
ToddShapiroShow @ToddShapiroShow
"Legalization - Everyone Looking To Be Part Of Movement" #HaloLabs' Kiran Sidhu w/ @iamToddyTickles $HALO https://t.co/Oxtq4LokRA
September 13th 2019, 1:09pm
TheDeepDive_ca @TheDeepDive_ca
$HALO halted pending news
September 13th 2019, 12:09pm
TickerReport @TickerReport
Halozyme Therapeutics $HALO Rating Lowered to Hold at ValuEngine https://t.co/Bq96neqF8g
September 13th 2019, 10:09am
ABiggzHD @ABiggzHD
Hit that Notification! Here is my Pre-Market Watchlist and game plan! $PCG - 11bln Settlement $HALO - Positive Re… https://t.co/hkZ9aqGHoG
September 13th 2019, 9:09am
BankTheTrade @BankTheTrade
$HALO(16.49) up 1.40 said pre-market Friday that a phase 3 FeDeriCa study evaluating a fixed-dose subcutaneous comb… https://t.co/LHIN0y59j8
September 13th 2019, 8:09am
Briefingcom @Briefingcom
$HALO: Halozyme Therapeutics reports Phase III FeDeriCa study met primary endpoint of non-inferiority https://t.co/mxMFVrcgFK
September 13th 2019, 8:09am
newswelldone @newswelldone
$HALO: Halozyme reports positive results from Perjeta + Herceptin …: https://t.co/1OGoSGZ8Ng
September 13th 2019, 7:09am
MarketCurrents @MarketCurrents
$HALO - Halozyme reports positive results from Perjeta + Herceptin combination study https://t.co/rItogbncP8
September 13th 2019, 7:09am
alertdata3 @alertdata3
RT @BioStocks: $HALO Global Phase 3 FeDeriCa Study Conducted By Genentech Met Its Primary Endpoint. https://t.co/yD5OYAtY5Z $RHHBY
September 13th 2019, 7:09am
BioStocks @BioStocks
$HALO Global Phase 3 FeDeriCa Study Conducted By Genentech Met Its Primary Endpoint. https://t.co/yD5OYAtY5Z $RHHBY
September 13th 2019, 6:09am
Gambiste1 @Gambiste1
RT @Wattwurm73: $CTMX $HALO BMY CEO at MS conference (min 29), data on next gen CTLA-4s next year, primarily phase 1
September 13th 2019, 6:09am
newsfilterio @newsfilterio
$HALO Halozyme Therapeutics announced that the... https://t.co/JKi8TUPDDe
September 13th 2019, 1:09am
Biotech2050 @Biotech2050
RT @Wattwurm73: $HALO Perjeta + Herceptin Fixed Dose SC combo (Enhanze) phase 3 results, primary endpoint non-inferiority met. https://t.co…
September 13th 2019, 1:09am
StockNewsWires @StockNewsWires
$HALO: Positive Results Announced From Phase 3 Trial Evaluating Fixed …: https://t.co/3Rye9cZmrz
September 13th 2019, 1:09am
Wattwurm73 @Wattwurm73
$HALO Perjeta + Herceptin Fixed Dose SC combo (Enhanze) phase 3 results, primary endpoint non-inferiority met. https://t.co/NiCAaseXMy
September 13th 2019, 1:09am
VisualStockRSRC @VisualStockRSRC
$HALO - Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of https://t.co/WqfWfVjo1z
September 13th 2019, 1:09am
iamtito_ @iamtito_
$HALO - Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of https://t.co/SjSLbC1mBh
September 13th 2019, 1:09am
Tickeron @Tickeron
$HALO's Aroon indicator reaches into Uptrend on September 11, 2019. View odds for this and other indicators:… https://t.co/Ei0hZkgxAv
September 12th 2019, 3:09pm
ConsumerFeed @ConsumerFeed
Halozyme Therapeutics $HALO Downgraded by ValuEngine https://t.co/9hQcVIArPb
September 12th 2019, 1:09pm
TickerReport @TickerReport
Halozyme Therapeutics, Inc. $HALO Receives Consensus Recommendation of “Hold” from Analysts https://t.co/Hyfln8Zr8d
September 12th 2019, 11:09am
AmericanBanking @AmericanBanking
Halozyme Therapeutics, Inc. $HALO Receives Consensus Recommendation of “Hold” from Analysts https://t.co/slEtZqHqA1 #stocks
September 12th 2019, 11:09am
stocknewstimes @stocknewstimes
Halozyme Therapeutics, Inc. $HALO Receives Consensus Recommendation of “Hold” from Analysts https://t.co/nPY1xKHdtW
September 12th 2019, 11:09am
dispatchtribune @dispatchtribune
Halozyme Therapeutics $HALO Rating Increased to Hold at Zacks Investment Research https://t.co/SXca0e3kPs
August 11th 2019, 3:08pm
OlympiaReport @OlympiaReport
Halozyme Therapeutics $HALO Rating Increased to Hold at Zacks Investment Research https://t.co/yFqvpupRiU
August 11th 2019, 3:08pm
Tickeron @Tickeron
$HALO in Uptrend: 50-day Moving Average moved above 200-day Moving Average on July 23, 2019. View odds for this and… https://t.co/5Ug4vabfAl
August 11th 2019, 1:08pm
TickerReport @TickerReport
Q3 2019 EPS Estimates for Halozyme Therapeutics, Inc. $HALO Boosted by Piper Jaffray Companies https://t.co/x45tenNz9i
August 11th 2019, 2:08am
TickerReport @TickerReport
Jefferies Financial Group Equities Analysts Boost Earnings Estimates for Halozyme Therapeutics, Inc. $HALO https://t.co/zXPy7Vp9xu
August 11th 2019, 2:08am
ConsumerFeed @ConsumerFeed
Q3 2019 EPS Estimates for Halozyme Therapeutics, Inc. $HALO Boosted by Piper Jaffray Companies https://t.co/MF2eYyFzG1
August 11th 2019, 1:08am
WatchlistN @WatchlistN
Halozyme Therapeutics $HALO Rating Increased to Hold at Zacks Investment Research https://t.co/5c1xTyifQ0
August 10th 2019, 6:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.